P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

January 2004

Features

Biotechnology Update

Advances in Treating Crohn’s Disease, Rheumatoid Arthritis, and Ankylosing Spondylitis: The “Dark Side” of Anti–Tumor Necrosis Factor Therapy

Dr. Goldenberg reviews the risks associated with some biological agents, which had been heralded as a breakthrough in the treatment of certain medical conditions.
Marvin M. Goldenberg, PhD, RPh, MS

A Pharmacist–Physician Antibiotic Support Team

The authors describe a pilot study during which many interventions resulted in a cost savings of more than $124,000 and enhanced patient care.
Timothy R. Pasquale, PharmD, Kenneth M. Komorny, PharmD, BCPS, Dorcas Letting-Mangira, PharmD, and Stephanie Peshek, PharmD

P&T Snapshot

Infliximab Therapy for Crohn’s Disease

The Impact of Implementing Community-Acquired Pneumonia Guidelines in a Rural Hospital

The authors explain how developing new guidelines at one hospital has improved the quality of care and has reduced the length of stay for patients with community-acquired pneumonia.
Paul D. Santos, PharmD, A. Frederick Hartman, MD, MPH, Susan S. Irving, RN, MPH, Sanjay Merchant, PhD, MBA, Brian Meissner, PharmD, Eileen M. Farrelly, MPH, and Kristine M. Floyd, PharmD

Commentary

Evidence: Is There Ever Enough?

Dr. Greengold discusses a moral and intellectual dilemma faced by P&T committees everywhere: deciding when there is enough evidence to add a drug to the formulary.
Nancy L. Greengold, MD, MBA

Drug Safety Revisions: FDA Update

Marvin M. Goldenberg, PhD, RPh, MS

Editorial Board Spotlight

Meet “Marvelous Marvin” Goldenberg

Sonja Sherritze

Departments

Editorial

Countering Counterfeiters

David Nash, MD, MBA, provides some options for countering the problem of counterfeit drugs.
David Nash, MD, MBA

Editor’s Memo

An Editor’s New Year’s Resolutions

Sonja Sherritze presents her modest New Year’s resolutions for P&T.
Sonja Sherritze

Prescription Washington

Major Changes Ahead: Medicare Drug Benefit to Affect the Entire Drug-Distribution Chain

Stephen Barlas discusses the ramifications of the new Medicare prescription drug benefit.
Stephen Barlas

Medication Errors

A Near-Fatal Pediatric Accident: Is It Time to Reassess a Common Cost-Cutting Measure?

Matthew Grissinger, RPh, FASCP, describes a near-fatal accident in a child after a syringe of medication was mistaken for a saline solution because of look-alike labeling.
Matthew Grissinger, RPh, FASCP

New Drugs/Drug News

P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new medical devices.

Drug Forecast

Hydroxyurea in the Treatment of Sickle Cell Anemia

The authors describe the role of hydroxyurea (Droxia®) in the treatment of sickle cell anemia.